万孚生物股价微跌1.03% 子公司9款检测试剂盒获批上市

Company Overview - Wanfu Biology's stock price as of July 29, 2025, is 24.12 yuan, down 0.25 yuan or 1.03% from the previous trading day [1] - The company specializes in the research, development, production, and sales of rapid diagnostic reagents and related instruments, covering areas such as infectious diseases, chronic diseases, and drug testing [1] Market Performance - The opening price on the same day was 24.37 yuan, with a high of 24.38 yuan and a low of 23.68 yuan [1] - The trading volume reached 3.92 billion yuan, with a turnover rate of 3.80% [1] Product Development - Wanfu Biology's wholly-owned subsidiary, Tianshen Medical, recently received approval for 9 self-developed test kits, including thrombosis detection and tumor marker detection reagents [1] - The company has accumulated 16 medical device registration certificates for its single-use chemiluminescence system, covering 9 major areas including cardiac markers, inflammation, and thrombosis [1] Financial Flow - On July 29, the net outflow of main funds was 21 million yuan, accounting for 0.2% of the circulating market value [1]